Transcriptional regulators of hepatic gluconeogenesis

Archives of Pharmacal Research

Volumn 36, Issue 2, 2013, Pages 189-200

  Oh, Kyoung Jin ^a   Han, Hye Sook ^a   Kim, Min Jung ^a   Koo, Seung Hoi ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Glucose metabolism; Liver; Transcriptional activator; Transcriptional co activator; Transcriptional repressor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FACTOR AF2; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE ACETYLTRANSFERASE PCAF; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; NUCLEAR RECEPTOR DAX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

BINDING AFFINITY; CELLULAR DISTRIBUTION; DIMERIZATION; DNA BINDING; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; FATTY ACID METABOLISM; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INNATE IMMUNITY; INSULIN SENSITIVITY; LIGAND BINDING; LIVER METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DNA INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE;

EID: 84879498729     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0018-5     Document Type: Review

References (102)

1. Accili, D.; and K.C. Arden. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426.
2. Alberts, A.S.; J. Arias, M. Hagiwara, M.R. Montminy, and J.R. Feramisco. 1994. Recombinant cyclic AMP response element binding protein (CREB) phosphorylated on Ser-133 is transcriptionally active upon its introduction into fibroblast nuclei. Journal of Biological Chemistry 269: 7623-7630.
3. Altarejos, J.Y.; and M. Montminy. 2011. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nature Reviews Molecular Cell Biology 12: 141-151.
4. Aranda, A.; and A. Pascual. 2001. Nuclear hormone receptors and gene expression. Physiological Reviews 81: 1269-1304.
5. Arias, J.; A.S. Alberts, P. Brindle, F.X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370: 226-229.
6. Ayala, J.E.; R.S. Streeper, J.S. Desgrosellier, S.K. Durham, A. Suwanichkul, C.A. Svitek, J.K. Goldman, F.G. Barr, D.R. Powell, and R.M. O'brien. 1999. Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence. Diabetes 48: 1885-1889.
7. Bailey, D.; C. Barreca, and P. O'hare. 2007. Trafficking of the bZIP transmembrane transcription factor CREB-H into alternate pathways of ERAD and stress-regulated intramembrane proteolysis. Traffic 8: 1796-1814.
8. Bailey, D.; and P. O'hare. 2007. Transmembrane bZIP transcription factors in ER stress signaling and the unfolded protein response. Antioxidants & Redox Signaling 9: 2305-2321.
9. Bannister, A.J.; and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643.
10. Barthel, A.; D. Schmoll, and T.G. Unterman. 2005. FoxO proteins in insulin action and metabolism. Trends in Endocrinology and Metabolism 16: 183-189.
11. Bedford, D.C.; L.H. Kasper, R. Wang, Y. Chang, D.R. Green, and P.K. Brindle. 2011. Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control. Cell Metabolism 14: 219-230.
12. Bedford, M.T.; and S.G. Clarke. 2009. Protein arginine methylation in mammals: who, what, and why. Molecular Cell 33: 1-13.
13. Behrens, J.; J.P. Von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
14. Biggs III, W.H.; J. Meisenhelder, T. Hunter, W.K. Cavenee, and K.C. Arden. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proceedings of the National Academy of Sciences of the United States of America 96: 7421-7426.
15. Brown, M.S.; and J.L. Goldstein. 2008. Selective versus total insulin resistance: a pathogenic paradox. Cell Metabolism 7: 95-96.
16. Brunet, A.; A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
17. Chanda, D.; J.H. Park, and H.S. Choi. 2008. Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocrine Journal 55: 253-268.
18. Chandak, G.R.; C.S. Janipalli, S. Bhaskar, S.R. Kulkarni, P. Mohankrishna, A.T. Hattersley, T.M. Frayling, and C.S. Yajnik. 2007. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50: 63-67.
19. Chin, K.T.; H.J. Zhou, C.M. Wong, J.M. Lee, C.P. Chan, B.Q. Qiang, J.G. Yuan, I.O. Ng, and D.Y. Jin. 2005. The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma. Nucleic Acids Research 33: 1859-1873.
20. Choi, D.; Oh KJ, H.S. Han, Y.S. Yoon, C.Y. Jung, S.T. Kim, and S.H. Koo. 2012a. Protein arginine methyltransferase-1 regulates hepatic glucose production in a FoxO1 dependent manner. Hepatology 56(4): 1546-1556.
21. Choi, D.; K.J. Oh, and S.H. Koo. 2012b. Involvement of multiple protein arginine methyltransferases in hepatic glucose metabolism. Hepatology. doi: 10.1002/hep.25939.
22. Chrivia, J.C.; R.P. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R.H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
23. Clevers, H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
24. Conkright, M.D.; G. Canettieri, R. Screaton, E. Guzman, L. Miraglia, J.B. Hogenesch, and M. Montminy. 2003a. TORCs: Transducers of regulated CREB activity. Molecular Cell 12: 413-423.
25. Conkright, M.D.; E. Guzman, L. Flechner, A.I. Su, J.B. Hogenesch, and M. Montminy. 2003b. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Molecular Cell 11: 1101-1108.
26. Daitoku, H.; M. Hatta, H. Matsuzaki, S. Aratani, T. Ohshima, M. Miyagishi, T. Nakajima, and A. Fukamizu. 2004. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proceedings of the National Academy of Sciences of the United States of America 101: 10042-10047.
27. Denboer, L.M.; P.W. Hardy-Smith, M.R. Hogan, G.P. Cockram, T.E. Audas, and R. Lu. 2005. Luman is capable of binding and activating transcription from the unfolded protein response element. Biochemical and Biophysical Research Communications 331: 113-119.
28. Dentin, R.; S. Hedrick, J. Xie, J. Yates III, and M. Montminy. 2008. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319: 1402-1405.
29. Erion, D.M.; I.D. Ignatova, S. Yonemitsu, Y. Nagai, P. Chatterjee, D. Weismann, J.J. Hsiao, D. Zhang, T. Iwasaki, R. Stark, C. Flannery, M. Kahn, C.M. Carmean, X.X. Yu, S.F. Murray, S. Bhanot, B.P. Monia, G.W. Cline, V.T. Samuel, and G.I. Shulman. 2009. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metabolism 10: 499-506.
30. Essers, M.A.; S. Weijzen, A.M. De Vries-Smits, I. Saarloos, N.D. De Ruiter, J.L. Bos, and B.M. Burgering. 2004. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO Journal 23: 4802-4812.
31. Gonzalez, G.A.; and M.R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680.
32. Grant, S.F.; G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, and K. Stefansson. 2006. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 38: 320-323.
33. Haeusler, R.A.; K.H. Kaestner, and D. Accili. 2010. FoxOs function synergistically to promote glucose production. Journal of Biological Chemistry 285: 35245-35248.
34. Hanson, R.W.; and L. Reshef. 1997. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annual Review of Biochemistry 66: 581-611.
35. Hayashi, T.; Y. Iwamoto, K. Kaku, H. Hirose, and S. Maeda. 2007. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 50: 980-984.
36. He, L.; A. Sabet, S. Djedjos, R. Miller, X. Sun, M.A. Hussain, S. Radovick, and F.E. Wondisford. 2009. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137: 635-646.
37. Helgason, A.; S. Palsson, G. Thorleifsson, S.F. Grant, V. Emilsson, S. Gunnarsdottir, A. Adeyemo, Y. Chen, G. Chen, I. Reynisdottir, R. Benediktsson, A. Hinney, T. Hansen, G. Andersen, K. Borch-Johnsen, T. Jorgensen, H. Schafer, M. Faruque, A. Doumatey, J. Zhou, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, G. Sigurdsson, J. Hebebrand, O. Pedersen, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, C. Rotimi, and K. Stefansson. 2007. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 39: 218-225.
38. Herzig, S.; F. Long, U.S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, P. Puigserver, B. Spiegelman, and M. Montminy. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413: 179-183.
39. Huber, O.; R. Korn, J. Mclaughlin, M. Ohsugi, B.G. Herrmann, and R. Kemler. 1996. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mechanisms of Development 59: 3-10.
40. Iourgenko, V.; W. Zhang, C. Mickanin, I. Daly, C. Jiang, J.M. Hexham, A.P. Orth, L. Miraglia, J. Meltzer, D. Garza, G.W. Chirn, E. Mcwhinnie, D. Cohen, J. Skelton, R. Terry, Y. Yu, D. Bodian, F.P. Buxton, J. Zhu, C. Song, and M.A. Labow. 2003. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 100: 12147-12152.
41. Iyer, A.K.; and E.R. Mccabe. 2004. Molecular mechanisms of DAX1 action. Molecular Genetics and Metabolism 83: 60-73.
42. Kim, D.H.; G. Perdomo, T. Zhang, S. Slusher, S. Lee, B.E. Phillips, Y. Fan, N. Giannoukakis, R. Gramignoli, S. Strom, S. Ringquist, and H.H. Dong. 2011. FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes 60: 2763-2774.
43. Kim, D.K.; D. Ryu, M. Koh, M.W. Lee, D. Lim, M.J. Kim, Y.H. Kim, W.J. Cho, C.H. Lee, S.B. Park, S.H. Koo, and H.S. Choi. 2012. Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis. Journal of Biological Chemistry 287: 21628-21639.
44. Kim, Y.D.; K.G. Park, Y.S. Lee, Y.Y. Park, D.K. Kim, B. Nedumaran, W.G. Jang, W.J. Cho, J. Ha, I.K. Lee, C.H. Lee, and H.S. Choi. 2008. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57: 306-314.
45. Koo, S.H.; L. Flechner, L. Qi, X. Zhang, R.A. Screaton, S. Jeffries, S. Hedrick, W. Xu, F. Boussouar, P. Brindle, H. Takemori, and M. Montminy. 2005. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437: 1109-1111.
46. Koo, S.H.; H. Satoh, S. Herzig, C.H. Lee, S. Hedrick, R. Kulkarni, R.M. Evans, J. Olefsky, and M. Montminy. 2004. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nature Medicine 10: 530-534.
47. Krones-Herzig, A.; A. Mesaros, D. Metzger, A. Ziegler, U. Lemke, J.C. Bruning, and S. Herzig. 2006. Signal-dependent control of gluconeogenic key enzyme genes through coactivator-associated arginine methyltransferase 1. Journal of Biological Chemistry 281: 3025-3029.
48. Kwok, R.P.; J.R. Lundblad, J.C. Chrivia, J.P. Richards, H.P. Bachinger, R.G. Brennan, S.G. Roberts, M.R. Green, and R.H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370: 223-226.
49. Lee, J.H.; P. Giannikopoulos, S.A. Duncan, J. Wang, C.T. Johansen, J.D. Brown, J. Plutzky, R.A. Hegele, L.H. Glimcher, and A.H. Lee. 2011. The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nature Medicine 17: 812-815.
50. Lee, J.M.; W.Y. Seo, K.H. Song, D. Chanda, Y.D. Kim, D.K. Kim, M.W. Lee, D. Ryu, Y.H. Kim, J.R. Noh, C.H. Lee, J.Y. Chiang, S.H. Koo, and H.S. Choi. 2010a. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner. Journal of Biological Chemistry 285: 32182-32191.
51. Lee, M.W.; D. Chanda, J. Yang, H. Oh, S.S. Kim, Y.S. Yoon, S. Hong, K.G. Park, I.K. Lee, C.S. Choi, R.W. Hanson, H.S. Choi, and S.H. Koo. 2010b. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor CREBH. Cell Metabolism 11: 331-339.
52. Lee, Y.S.; D. Chanda, J. Sim, Y.Y. Park, and H.S. Choi. 2007. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. International Review of Cytology 261: 117-158.
53. Lehman, D.M.; K.J. Hunt, R.J. Leach, J. Hamlington, R. Arya, H.E. Abboud, R. Duggirala, J. Blangero, H.H. Goring, and M.P. Stern. 2007. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56: 389-393.
54. Lehtinen, M.K.; Z. Yuan, P.R. Boag, Y. Yang, J. Villen, E.B. Becker, S. Dibacco, N. De La Iglesia, S. Gygi, T.K. Blackwell, and A. Bonni. 2006. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001.
55. Lin, J.; C. Handschin, and B.M. Spiegelman. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metabolism 1: 361-370.
56. Lin, J.; P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C.Y. Zhang, V.K. Mootha, S. Jager, C.R. Vianna, R.M. Reznick, L. Cui, M. Manieri, M.X. Donovan, Z. Wu, M.P. Cooper, M.C. Fan, L.M. Rohas, A.M. Zavacki, S. Cinti, G.I. Shulman, B.B. Lowell, D. Krainc, and B.M. Spiegelman. 2004. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-135.
57. Liu, Y.; R. Dentin, D. Chen, S. Hedrick, K. Ravnskjaer, S. Schenk, J. Milne, D.J. Meyers, P. Cole, J. Yates III, J. Olefsky, L. Guarente, and M. Montminy. 2008. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456: 269-273.
58. Mangelsdorf, D.J.; C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
59. Matsumoto, M.; A. Pocai, L. Rossetti, R.A. Depinho, and D. Accili. 2007. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metabolism 6: 208-216.
60. Molenaar, M.; M. Van De Wetering, M. Oosterwegel, J. Peterson-Maduro, S. Godsave, V. Korinek, J. Roose, O. Destree, and H. Clevers. 1996. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
61. Moore, M.C.; C.C. Connolly, and A.D. Cherrington. 1998. Autoregulation of hepatic glucose production. European Journal of Endocrinology 138: 240-248.
62. Motta, M.C.; N. Divecha, M. Lemieux, C. Kamel, D. Chen, W. Gu, Y. Bultsma, M. Mcburney, and L. Guarente. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563.
63. Nakae, J.; B.C. Park, and D. Accili. 1999. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. Journal of Biological Chemistry 274: 15982-15985.
64. Nedumaran, B.; S. Hong, Y.B. Xie, Y.H. Kim, W.Y. Seo, M.W. Lee, C.H. Lee, S.H. Koo, and H.S. Choi. 2009. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression. Journal of Biological Chemistry 284: 27511-27523.
65. Nordlie, R.C.; J.D. Foster, and A.J. Lange. 1999. Regulation of glucose production by the liver. Annual Review of Nutrition 19: 379-406.
66. Norton, L.; M. Fourcaudot, M.A. Abdul-Ghani, D. Winnier, F.F. Mehta, C.P. Jenkinson, and R.A. Defronzo. 2011. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 54: 3132-3142.
67. Ogryzko, V.V.; R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
68. Oh, K.J.; J. Park, S.S. Kim, H. Oh, C.S. Choi, and S.H. Koo. 2012. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. PLoS Genetics 8: e1002986.
69. Panagopoulos, I.; E. Moller, A. Dahlen, M. Isaksson, N. Mandahl, A. Vlamis-Gardikas, and F. Mertens. 2007. Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera. Genes, Chromosomes and Cancer 46: 181-191.
70. Pilkis, S.J.; and T.H. Claus. 1991. Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annual Review of Nutrition 11: 465-515.
71. Pilkis, S.J.; M.R. El-Maghrabi, and T.H. Claus. 1988. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annual Review of Biochemistry 57: 755-783.
72. Postic, C.; R. Dentin, P.D. Denechaud, and J. Girard. 2007. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annual Review of Nutrition 27: 179-192.
73. Puigserver, P.; G. Adelmant, Z. Wu, M. Fan, J. Xu, B. O'malley, and B.M. Spiegelman. 1999. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 286: 1368-1371.
74. Puigserver, P.; J. Rhee, J. Donovan, C.J. Walkey, J.C. Yoon, F. Oriente, Y. Kitamura, J. Altomonte, H. Dong, D. Accili, and B.M. Spiegelman. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423: 550-555.
75. Puigserver, P.; Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-839.
76. Rubinfeld, B.; P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, and P. Polakis. 1997. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792.
77. Ryu, D.; K.J. Oh, H.Y. Jo, S. Hedrick, Y.N. Kim, Y.J. Hwang, T.S. Park, J.S. Han, C.S. Choi, M. Montminy, and S.H. Koo. 2009. TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1. Cell Metabolism 9: 240-251.
78. Saberi, M.; D. Bjelica, S. Schenk, T. Imamura, G. Bandyopadhyay, P. Li, C. Vargeese, W. Wang, K. Bowman, Y. Zhang, B. Polisky, and J.M. Olefsky. 2009. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. American Journal of Physiology, Endocrinology and Metabolism 297(5): E1137-E1146.
79. Saltiel, A.R.; and C.R. Kahn. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
80. Seol, W.; H.S. Choi, and D.D. Moore. 1996. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272: 1336-1339.
81. Shu, L.; N.S. Sauter, F.T. Schulthess, A.V. Matveyenko, J. Oberholzer, and K. Maedler. 2008. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57: 645-653.
82. Stirling, J.; and P. O'hare. 2006. CREB4, a transmembrane bZip transcription factor and potential new substrate for regulation and cleavage by S1P. Molecular Biology of the Cell 17: 413-426.
83. Takahashi, Y.; H. Daitoku, K. Hirota, H. Tamiya, A. Yokoyama, K. Kako, Y. Nagashima, A. Nakamura, T. Shimada, S. Watanabe, K. Yamagata, K. Yasuda, N. Ishii, and A. Fukamizu. 2011. Asymmetric arginine dimethylation determines life span in C. elegans by regulating forkhead transcription factor DAF-16. Cell Metabolism 13: 505-516.
84. Tanaka, Y.; I. Naruse, T. Maekawa, H. Masuya, T. Shiroishi, and S. Ishii. 1997. Abnormal skeletal patterning in embryos lacking a single Cbp allele: A partial similarity with Rubinstein-Taybi syndrome. Proceedings of the National Academy of Sciences of the United States of America 94: 10215-10220.
85. Towle, H.C.; E.N. Kaytor, and H.M. Shih. 1997. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annual Review of Nutrition 17: 405-433.
86. Uyeda, K.; and J.J. Repa. 2006. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metabolism 4: 107-110.
87. Van Der Horst, A.; L.G. Tertoolen, L.M. De Vries-Smits, R.A. Frye, R.H. Medema, and B.M. Burgering. 2004. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). Journal of Biological Chemistry 279: 28873-28879.
88. Van Schaftingen, E.; and I. Gerin. 2002. The glucose-6-phosphatase system. The Biochemical Journal 362: 513-532.
89. Vecchi, C.; G. Montosi, K. Zhang, I. Lamberti, S.A. Duncan, R.J. Kaufman, and A. Pietrangelo. 2009. ER stress controls iron metabolism through induction of hepcidin. Science 325: 877-880.
90. Wadzinski, B.E.; W.H. Wheat, S. Jaspers, L.F. Peruski Jr, R.L. Lickteig, G.L. Johnson, and D.J. Klemm. 1993. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Molecular and Cellular Biology 13: 2822-2834.
91. Wallberg, A.E.; S. Yamamura, S. Malik, B.M. Spiegelman, and R.G. Roeder. 2003. Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha. Molecular Cell 12: 1137-1149.
92. Wang, Y.; H. Inoue, K. Ravnskjaer, K. Viste, N. Miller, Y. Liu, S. Hedrick, L. Vera, and M. Montminy. 2010. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 107: 3087-3092.
93. Wang, Y.; G. Li, J. Goode, J.C. Paz, K. Ouyang, R. Screaton, W.H. Fischer, J. Chen, I. Tabas, and M. Montminy. 2012. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. Nature 485: 128-132.
94. Xu, Z.; Y. Wang, and H. Liu. 2012. Protein arginine methylation in hepatic glucose metabolism regulation: Histone, or non-histone? That is the question. Hepatology. doi: 10.1002/hep.25943.
95. Yamagata, K.; H. Daitoku, Y. Takahashi, K. Namiki, K. Hisatake, K. Kako, H. Mukai, Y. Kasuya, and A. Fukamizu. 2008. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Molecular Cell 32: 221-231.
96. Yamauchi, T.; Y. Oike, J. Kamon, H. Waki, K. Komeda, A. Tsuchida, Y. Date, M.X. Li, H. Miki, Y. Akanuma, R. Nagai, S. Kimura, T. Saheki, M. Nakazato, T. Naitoh, K. Yamamura, and T. Kadowaki. 2002. Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nature Genetics 30: 221-226.
97. Yao, T.P.; S.P. Oh, M. Fuchs, N.D. Zhou, L.E. Ch'ng, D. Newsome, R.T. Bronson, E. Li, D.M. Livingston, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361-372.
98. Yi, F.; P.L. Brubaker, and T. Jin. 2005. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. Journal of Biological Chemistry 280: 1457-1464.
99. Yoon, J.C.; P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C.R. Kahn, D.K. Granner, C.B. Newgard, and B.M. Spiegelman. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131-138.
100. Yoon, Y.S.; M.W. Lee, D. Ryu, J.H. Kim, H. Ma, W.Y. Seo, Y.N. Kim, S.S. Kim, C.H. Lee, T. Hunter, C.S. Choi, M.R. Montminy, and S.H. Koo. 2010. Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis. Proceedings of the National Academy of Sciences of the United States of America 107: 17704-17709.
101. Zhang, K.; X. Shen, J. Wu, K. Sakaki, T. Saunders, D.T. Rutkowski, S.H. Back, and R.J. Kaufman. 2006. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587-599.
102. Zinker, B.; A. Mika, P. Nguyen, D. Wilcox, L. Ohman, T.W. Von Geldern, T. Opgenorth, and P. Jacobson. 2007. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance. Metabolism 56: 380-387.